
Akeso
OrganizationHeard in 4 episodes across 2 shows since Sep 2026
Akeso, Inc. is a China-based biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines, particularly in oncology and other major therapeutic areas.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 0 |
| Nov 2026 | 2 |
Email alert
Email me when Akeso comes up on a podcast
One email a week at most, with the new episodes that mention Akeso. Free, no account needed, unsubscribe in one click.
What experts have said about Akeso
2 statements · 2 positive
Akeso shares rose 17% and led Hong Kong’s HS Bio market.
“Summit's partner, Akeso, is up 17% to lead the HS Bio in Hong Kong.”
Open the episode · MediaTek Dips, Akeso Rises, NSEBANK DownListen at 2:23
Akeso shares rose 17%, leading Hong Kong’s HS Bio market.
“Summit's partner, Akeso, is up 17% to lead the HS Bio in Hong Kong.”
Open the episode · MediaTek Dips, Akeso Rises, NSEBANK DownListen at 2:23
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Akeso, newest first
- Nov 20, 2026
FDA leadership falters as China biotech reshapes drug competitionThe Readout LoudNov 20, 2026 - Nov 16, 2026
Nvidia faces leadership questions as market pressure spreadsStock MoversNov 16, 2026 - Sep 29, 2026
Asian stocks wobble as AI doubts meet drugmaking dealsStock MoversSep 29, 2026 - Sep 24, 2026
Chinese tech shares confront an AI credibility testStock MoversSep 24, 2026